Literature DB >> 15969983

Understanding the role of gender in the incidence of thyroid cancer.

Steven K Libutti1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15969983     DOI： 10.1097/00130404-200503000-00003

Source DB:  PubMed          Journal:  Cancer J        ISSN： 1528-9117            Impact factor:   3.360


× No keyword cloud information.
  6 in total

1.  17β-Estradiol activates Cl- channels via the estrogen receptor α pathway in human thyroid cells.

Authors:  Meisheng Yu; Yuan Wei; Yanfang Zheng; Lili Yang; Long Meng; Jiawei Lin; Peisheng Xu; Sanaa Ahmed Nagi Abdu Mahdy; Linyan Zhu; Shuang Peng; Lixin Chen; Liwei Wang
Journal:  Channels (Austin)       Date:  2021-12       Impact factor: 2.581

2.  Cross-talk between PI3K and estrogen in the mouse thyroid predisposes to the development of follicular carcinomas with a higher incidence in females.

Authors:  V G Antico-Arciuch; M Dima; X-H Liao; S Refetoff; A Di Cristofano
Journal:  Oncogene       Date:  2010-08-02       Impact factor: 9.867

3.  Old and new insights in the treatment of thyroid carcinoma.

Authors:  Joan Manel Gasent Blesa; Enrique Grande Pulido; Mariano Provencio Pulla; Vicente Alberola Candel; Juan Bautista Laforga Canales; Miguel Grimalt Arrom; Patricia Martin Rico
Journal:  J Thyroid Res       Date:  2010-04-13

Review 4.  Risk Factors for Central Lymph Node Metastasis in CN0 Papillary Thyroid Carcinoma: A Systematic Review and Meta-Analysis.

Authors:  Wei Sun; Xiabin Lan; Hao Zhang; Wenwu Dong; Zhihong Wang; Liang He; Ting Zhang; Siming Liu
Journal:  PLoS One       Date:  2015-10-02       Impact factor: 3.240

5.  Aberrant Expression of Androgen Receptor Associated with High Cancer Risk and Extrathyroidal Extension in Papillary Thyroid Carcinoma.

Authors:  Chen-Kai Chou; Shun-Yu Chi; Fong-Fu Chou; Shun-Chen Huang; Jia-He Wang; Chueh-Chen Chen; Hong-Yo Kang
Journal:  Cancers (Basel)       Date:  2020-04-29       Impact factor: 6.639

6.  Predictive factors for non-small-volume central lymph node metastases (more than 5 or ≥ 2 mm) in clinically node-negative papillary thyroid carcinoma.

Authors:  Jian-Biao Wang; Ya-Yu Sun; Liu-Hong Shi; Lei Xie
Journal:  Medicine (Baltimore)       Date:  2019-01       Impact factor: 1.889
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.